Colombia vs Jordan: Access to anti-retroviral drugs, male
Colombia
64.0%
in 2023
Jordan
64.0%
in 2024
Colombia rank
87th
Jordan rank
87th
Access to anti-retroviral drugs, male over time
- Colombia
- Jordan
How they compare
Colombia currently reports 64.0% against 64.0% in Jordan, a difference of 0.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Jordan ahead.
Colombia ranks 87th and Jordan ranks 87th of 141 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Jordan in 2.
Head to head by decade
| Decade | Colombia | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 20.6% | 15.0% | Jordan |
| 2010s | 34.1% | 42.9% | 8.8% | Jordan |
| 2020s | 60.2% | 51.2% | 9.0% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Colombia or Jordan?
- Colombia, at 64.0% against 64.0% in Jordan as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Colombia and Jordan?
- 0.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Jordan?
- 24 years are reported by both, from 2000 to 2023.
- How do Colombia and Jordan rank globally for access to anti-retroviral drugs, male?
- Colombia ranks 87th and Jordan ranks 87th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.